Data on NMS in genetic PD are limited. Specific data needs include a systematic approach to NMS assessment reporting permitting comparability of studies. Overall, the frequency of NMS in genetic PD does not appear to be higher and may even be lower than in idiopathic PD. Nonmotor symptoms have a high impact on the patients' quality of life and caregiver burden and should be considered important and often treatable concomitant features of genetic PD.
No takes yet. Share an insight, caveat, or question.
Kasten et al. (2010) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: